Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Tejpat Leaf (Cinnamomum tamala) contains cinnamaldehyde as its primary bioactive compound, demonstrating antioxidant and anti-inflammatory activity by enhancing superoxide dismutase and catalase enzyme activity. The leaf's polyphenols and eugenol contribute to its traditional use for blood sugar modulation and digestive support.
Reported Benefits (Provisional)
Origin & History
Cinnamomum tamala (Tejpat Leaf) is an aromatic botanical native to the mid-elevation Himalayan forests and subtropical regions of India, Nepal, Bhutan, and northern Myanmar. Traditionally revered in Ayurvedic and Buddhist practices, it is valued for its metabolic balancing, digestive, and respiratory support properties.
Research Narrative (Provisional)
Preliminary in vitro and animal studies suggest Tejpat Leaf's potential in modulating blood glucose and lipid profiles. Research also indicates its antioxidant and anti-inflammatory properties, supporting its traditional uses for metabolic and digestive health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamin C: Supports immunity and cellular protection. - Calcium, potassium, and magnesium: Promote nerve health, muscular balance, and hydration. - Cinnamaldehyde, eugenol, cineole, linalool: Aromatic oils supporting digestion, metabolism, and respiratory health. - Flavonoids (quercetin, kaempferol): Provide antioxidant and anti-inflammatory benefits. - Tannins: Contribute to vascular health and astringent properties.
Reported Mechanism (Provisional)
Cinnamaldehyde and eugenol provide the primary therapeutic effects by scavenging free radicals and inducing antioxidant enzymes including superoxide dismutase (SOD) and catalase (CAT). The polyphenolic compounds quercetin, kaempferol, and apigenin reduce oxidative stress through cellular protection pathways. Alpha-pinene contributes bronchodilatory effects while the sesquiterpenoids furanogermenone and germacren D enhance the overall anti-inflammatory response.
Clinical Narrative (Provisional)
Current evidence is limited to preliminary in vitro and animal studies demonstrating nephroprotective effects against gentamicin-induced toxicity and anticancer activity via bornyl acetate. No human randomized controlled trials have been published providing quantified clinical outcomes such as percentage improvements in blood glucose or lipid profiles. Preclinical research supports antioxidant and anti-inflammatory properties, but lacks specific effect sizes, p-values, or standardized dosing protocols. The absence of clinical trial data significantly limits evidence-based therapeutic recommendations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.